Molecular characterization of hepatitis B virus surface antigen mutants in Singapore patients with hepatocellular carcinoma and hepatitis B virus carriers negative for HBsAg but positive for anti-HBs and anti-HBc

Journal of Gastroenterology and Hepatology (Australia)

Volumn 17, Issue SUPPL. 4, 2002, Pages

  Chong, Jin Oon ^a   Wei, Ning Chen ^a   Kee, Tai Goh ^a   Mesenas, Steven ^a   Han, Seong Ng ^a   Chiang, Gilbert ^a   Tan, Clarence ^a   Koh, Shiuan ^a   Siaw, Wei Teng ^a   Toh, Ivy ^a   Mei, Chung Moh ^a   Kian, Sim Goo ^a   Tan, Kaeling ^a   Ai, Lin Leong ^a   Gek, San Tan ^a  

^a NONE

Author keywords

Hepatitis B; Hepatoma; Seronegative; Suface mutants

Indexed keywords

GENOMIC DNA; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADOLESCENT; ADULT; AGED; ANTIGEN STRUCTURE; ARTICLE; CELL LINE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENOME; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IN VITRO STUDY; INFANT; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MUTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; VACCINATION; VIRUS CARRIER;

EID: 12244273050     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.17.s4.16.x     Document Type: Article

References (32)

1. Kane MA. Status of hepatitis B immunization programmes in 1998. Vaccine 1998; 16: S104-8.
2. Howard CR, Allison LMC. Hepatitis B surface antigen variation and protective immunity. Intervirology 1995; 38: 35-40.
3. Carman WF, Zanetti AR, Karayiannis P et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet1990; 336: 325-9.
4. Oon CJ, Lim GK, Ye Zet al. Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine 1995; 13: 699-702.
5. Okamoto H, Yano K, Nozaki Y et al. Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine. Pediatr. Res. 1992; 32: 264-8.
6. Lee PI, Chang LY, Lee CY, Huang LM, Chang MH. Detection of hepatitis B surface gene mutation in carrier children with or without immunoprophylaxis at birth. J. Infect. Dis. 1997; 176: 427-30.
7. Oon CJ, Chen WN. Current aspects of hepatitis B surface antigen mutants in Singapore. J. Viral Hepat. 1998; 5: 17-23.
8. Carman WF, Van Deursen FJ, Mimms LT et al.The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia. Hepatology 1997; 26: 1658-66.
9. Ogata N, Zanetti AR, Yu M, Miller RH, Purcell RH. Infectivity and pathogenicity in chimpanzees of a surface gene mutant of hepatitis B virus that emerged in a vaccinated infant. J. Infect. Dis. 1997; 175: 511-23.
10. Carman WF, Korula J, Wallace L, MacPhee R, Mimms L, Decker R. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by mon-oclonal HBsAg ELISA. Lancet 1995; 345: 1406-7.
11. Hsu HY, Chang MH, Ni YH, Lin HH, Wang SM, Chen DS. Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis. Hepatology1997; 26: 786-91.
12. Oon CJ, Chen WN, Zhao Y, Teng SW, Leong AL. Detection of hepatitis B virus surface antigen mutants and their integration in human hepatocellular carcinoma. Cancer Lett. 1999; 136: 95-9.
13. Chen WN, Oon CJ. Hepatitis B virus surface antigen mutants in Singapore adults and vaccinated infants with high anti-HBs levels but negative for surface antigen. J. Clin. Microbiol. 2000; 38: 2793-4.
14. Weinberger KM, Bauer T, Bohm S, Jilg W. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J. Gen. Virol. 2000; 81: 1165-74.
15. Oon CJ, Chen WN, Koh S, Lim GK. Identification of hepatitis B surface antigen variants with alterations outside the 'a' determinant in immunized Singapore infants. J. Infect. Dis. 1999b; 179: 259-63.
16. Chen WN, Oon CJ, Moh MC. Detection of hepatitis B surface antigen mutants in paraffin-embedded hepatocellular carcinoma tissues. Virus Genes2000; 20: 263-7.
17. Diaz-Cano SJ, Brady SP. DNA extraction from formalin-fixed, paraffin-embedded tissues: protein digestion as a limiting step for retrieval of high-quality DNA. Diagn. Mol. Pathol. 1997; 6: 342-6.
18. Chen WN, Oon CJ, Toh I. Altered antigenicities of hepatitis B virus surface antigen carrying mutations outside the common 'a' determinant. Am. J. Gastroenterol. 2000; 95: 1098-9.
19. Oon CJ, Chen WN, Lim N et al. Hepatitis B virus variants with lamivudine-related mutations in the DNA poly-merase and the 'a' epitope of the surface antigen are sensitive to ganciclovir. Antiviral. Res. 2000; 41: 113-18.
20. Cabrerizo M, Bartolome J, De Sequera P, Caramelo C, Carreno V. Hepatitis B virus DNA in serum and blood cells of hepatitis B surface antigen-negative hemodialysis patients and staff. J. Am. Soc. Nephrol. 1997; 8: 1443-7.
21. Scully LJ, Sung H, Pennie R, Gill P. 1994. Detection of hepatitis B virus DNA in the serum of Canadian hepatitis B surface antigen negative, anti-HBc positive individuals, using the polymerase chain reaction. J. Med. Virol. 1994; 44: 293-7.
22. Chen WN, Oon CJ. Human hepatitis B virus mutants: significance of molecular changes. FEBS Lett. 1999; 453: 237-42.
23. Weiss L, Kekule AS, Jakubowski U, Burgelt E, Hofschneider PH. The HBV-producing cell line HepG2-4A5: a new in vitro system for studying the regulation of HBV replication and for screening anti-hepatitis B virus drugs. Virology 1996; 216: 214-18.
24. Takahashi K, Akahane Y, Hino K, Ohta Y, Mishiro S. Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients: comparative analysis of 40 full-length isolates. Arch. Virol. 1998; 143: 2313-26.
25. Zhong 5, Chan JY, Yeo W, Tam JS, Johnson PJ. Hepatitis B envelope protein mutants in human hepatocellular carcinoma tissues. J. Viral. Hepat. 1999; 6: 195-202.
26. Oon CJ. Evolution and transmission of hepatitis B virus mutants. In Zuckerman AJ, ed. Hepatitis B in the Asia-Pacific region Royal College of Physicians, London, UK, 1997; 177-90.
27. Zhang YY, Nordenfelt E, Hansson BG. Increasing heterogeneity of the 'a' determinant of HBsAg found in the presumed late phase of chronic hepatitis B virus infection. Scand. J. Infect. Dis. 1996; 28: 9-15.
28. Alka S, Hemlata D, Vaishali C, Shahid J, Kumar PS. Hepatitis B virus surface (S) transactivator with DNA-binding properties. J. Med. Virol. 2000; 61: 1-10.
29. Hildt E, Saher G, Bruss V, Hofshneider PH. The hepatitis B virus large surface protein (LHBs) is a transcriptional activator. Virology 1996; 225: 235-9.
30. Caselmann WH, Renner M, Schluter V, Hofschneider PH, Koshy R, Meyer M. The hepatitis B virus MHBst167 protein is a pleiotropic transactivator mediating its effect via ubiquitous cellular transcription factors. J. Gen. Virol. 1997; 78: l487-95.
31. Chen WN, Oon CJ, Koh S. Horizontal transmission of a human hepatitis B virus surface antigen mutant. J. Clin. Microbiol. 2000; 38: 938-9.
32. Jongerius JM, Wester M, Cuypers HT et al. New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays. Transfusion 1998; 38: 56-9.